How does discharge against medical advice affect risk of mortality and unplanned readmission? A retrospective cohort study set in a large UK medical admissions unit.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
27 03 2023
Historique:
medline: 29 3 2023
entrez: 27 3 2023
pubmed: 28 3 2023
Statut: epublish

Résumé

To assess the frequency of discharge against medical advice (DAMA) in a large UK teaching hospital, explore factors which increase the risk of DAMA and identify how DAMA impacts patient risk of mortality and readmission. Retrospective cohort study. Large acute teaching hospital in the UK. 36 683 patients discharged from the acute medical unit of a large UK teaching hospital between 1 January 2012 and 31 December 2016. Patients were censored on 1 January 2021. Mortality and 30-day unplanned readmission rates were assessed. Deprivation, age and sex were taken as covariates. 3% of patients discharged against medical advice. These patients were younger (median age (years) (IQR)): planned discharge (PD) 59 (40-77); DAMA 39 (28-51), predominantly of male sex (PD 48%; DAMA 66%) and were of greater social deprivation (in three most deprived quintiles PD 69%; DAMA 84%). DAMA was associated with increased risk of death in patients under the age of 33.3 years (adjusted HR 2.6 (1.2-5.8)) and increased incidence of 30-day readmission (standardised incidence ratio 1.9 (1.5-2.2)). Readmission to acute hospitals outside of the local health board may have been missed. We were unable to include information regarding comorbidity or severity of presentation. These data highlight the vulnerability of younger patients who DAMA, even in a free-at-the-point-of-delivery healthcare setting.

Identifiants

pubmed: 36972969
pii: bmjopen-2022-068801
doi: 10.1136/bmjopen-2022-068801
pmc: PMC10069606
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e068801

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Public Health. 2007 Dec;97(12):2204-8
pubmed: 17971552
Mayo Clin Proc. 2017 Apr;92(4):525-535
pubmed: 28291588
Qual Health Res. 2018 Apr;28(5):702-710
pubmed: 29415637
Mayo Clin Proc. 2009 Mar;84(3):255-60
pubmed: 19252113
Healthcare (Basel). 2021 Jan 21;9(2):
pubmed: 33494294
J Gen Intern Med. 1998 Aug;13(8):568-71
pubmed: 9734795
Int J Health Policy Manag. 2013 Jun 21;1(2):137-42
pubmed: 24596853
Int J Clin Pract. 2002 Jun;56(5):325-7
pubmed: 12137437
Hosp Formul. 1980 Apr;15(4):273, 276-7
pubmed: 10245910
J Gen Intern Med. 2000 Feb;15(2):103-7
pubmed: 10672113
Am J Med. 2012 Jun;125(6):594-602
pubmed: 22513194
N Engl J Med. 1979 Jan 4;300(1):22-4
pubmed: 758156
CMAJ. 2003 Feb 18;168(4):417-20
pubmed: 12591781
J Healthc Risk Manag. 2009;29(2):6-9, 13, 15
pubmed: 19908647
JAMA. 1979 Dec 21;242(25):2758
pubmed: 501872
JAMA Netw Open. 2020 Jun 1;3(6):e206009
pubmed: 32525546
J Gen Intern Med. 2010 Sep;25(9):926-9
pubmed: 20425146
J Allergy Clin Immunol. 2007 Apr;119(4):924-9
pubmed: 17239431

Auteurs

Anand Alagappan (A)

Acute & General Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

Thomas J G Chambers (TJG)

Centre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK tom.chambers@ed.ac.uk.
Metabolic Unit, Western General Hospital, Edinburgh, UK.

Erik Brown (E)

Lothian Analytical Services, Waverley Gate, NHS Lothian, Edinburgh, UK.

Sheila M Grecian (SM)

Metabolic Unit, Western General Hospital, Edinburgh, UK.

Khalida Ann Lockman (KA)

Acute & General Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
Department of Acute Medicine, The University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH